# Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients

> **NCT01942460** · PHASE4 · COMPLETED · sponsor: **Georges Ouellet** · enrollment: 15 (actual)

## Conditions studied

- Iron-Deficiency Anemia
- Inflammation
- Oxidative Stress

## Interventions

- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT01942460
- **Lead sponsor:** Georges Ouellet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942460, "Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01942460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*